How we turn ambition into shipped platforms.
A disciplined five-phase model honed across government, healthcare and financial engagements. Every gate has a measurable outcome — not just a deliverable.
Phase 01
1–3 weeks
Discovery
Stakeholder interviews, current-state assessment and an evidence-led problem statement. We frame outcomes in business terms — not features.
Key deliverables
- Diagnostic report
- Use-case shortlist
- Success metrics & KPIs
- Risk register
Phase 02
2–4 weeks
Design
Target architecture, data model, UX flows and a costed delivery plan you can take to your board.
Key deliverables
- Architecture diagrams
- Interactive prototype
- Data & integration map
- Phased roadmap
Phase 03
6–16 weeks
Build
Bi-weekly sprints with working software at every demo. Code reviewed, tests in CI, security scanned automatically.
Key deliverables
- Production-grade code
- Test coverage reports
- CI/CD pipelines
- Runbooks
Phase 04
2–4 weeks
Launch
Staged rollout with feature flags, observability turned on day one and a clear go/no-go gate before each cohort.
Key deliverables
- Cutover plan
- Training collateral
- Hypercare schedule
- Adoption metrics
Phase 05
Ongoing
Operate
Managed operations or knowledge transfer to your team — your choice. Quarterly business reviews keep outcomes honest.
Key deliverables
- SLOs & SLAs
- Incident response
- Quarterly reviews
- Capability uplift
Outcomes over outputs.
Sprint demos optional, working software mandatory. Every two weeks you see what moved — not a status deck.
- Single-threaded engagement lead — one accountable owner
- Embedded with your team in your tools (Slack, Jira, GitHub)
- Decisions documented as lightweight ADRs
- No work-in-progress hidden behind status colors
- Quarterly business reviews tied to the KPIs we set in discovery
- Knowledge transfer is a deliverable, not a closing checklist
Start with discovery
A focused diagnostic, in three weeks.
The fastest way to know if Nova is the right partner is to run the discovery phase together. Fixed scope, fixed price, no commitment to phase two.